SFI
IMGN

Susquehanna Fundamental Investments’s Immunogen Inc IMGN Stock Holding History

Susquehanna Fundamental Investments’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-59,944
Closed -$340K – 1823
2021
Q3 		$340K Sell
59,944
-58,655
-49% -$339K 0.01% 1359
2021
Q2 		$782K Buy
118,599
+21,490
+22% +$150K 0.01% 965
2021
Q1 		$787K Hold
97,109
– – 0.01% 981
2020
Q4 		$626K Buy
97,109
+86,135
+785% +$502K 0.01% 1023
2020
Q3 		$40K Buy
+10,974
New +$44.3K ﹤0.01% 1328

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna Fundamental Investments's IMGN Position: Q4 2021 in Review

Susquehanna Fundamental Investments sold out of Immunogen Inc (IMGN) in Q4 2021, closing a stake of 59,944 shares — an estimated $340K sold.

Susquehanna Fundamental Investments first reported a position in IMGN in Q3 2020 and held it in 5 quarters. The position peaked at $787K in Q1 2021. 236 funds tracked by Wall St. Rank hold IMGN as of Q4 2021.

  • Susquehanna Fundamental Investments reported no remaining Immunogen Inc position as of Q4 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 59,944 Immunogen Inc shares in Q4 2021, an estimated $340K.
  • Susquehanna Fundamental Investments first reported a position in Immunogen Inc in Q3 2020 and held it in 5 quarters.
  • Susquehanna Fundamental Investments's Immunogen Inc position peaked at $787K in Q1 2021.
  • 236 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2021, filed 14 Feb 2022.